RPAF-AH Uses, Dosage, Side Effects and more
RPAF-AH is under investigation in clinical trial NCT00037687 (Safety and Efficacy of Recombinant Human Platelet-activating Factor Acetylhydrolase for the Treatment of Severe Sepsis).
| Attribute | Details |
|---|---|
| Trade Name | RPAF-AH |
| Generic | Epafipase |
| Epafipase Other Names | Epafipase, RPAF-AH |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
